Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Cantor Fitzgerald says 15% of biotech companies down 40% or more
-
Rocket Pharmaceuticals (RCKT) PT Lowered to $50 at Cantor Fitzgerald
-
Rocket Pharmaceuticals (RCKT) Prices Upsized 13.2M Share Offering at $12.50/sh
-
Rocket Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
-
Rocket Pharmaceuticals (RCKT) Announces Proposed Public Offering of Common Stock
-
Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Today's most important initiations
-
Rocket Pharmaceuticals Announces Participation at Upcoming Conferences
